Amarin Corp Plc (AMRN)

[sts66]

Patents aren't awarded for running expensive trials - in fact, you need to file for them *before* you start even talking about such a trial - once your theory is public, you can't patent it. And R-IT didn't exactly prove the value or non-value of biomarkers wrt to CVD risk - but some day I hope they'll release the Lp-PLA2 level correlation with risk levels - won't be a patent issue, but will really help clinicians.